Star Equity (STRR) Competitors

$10.69 +0.58 (+5.78%)

Closing price 03:59 PM Eastern

Extended Trading

$10.70 +0.00 (+0.01%)

As of 05:48 PM Eastern

STRR vs. CVRX, RCEL, NNOX, HSDT, and NYXH

Should you buy Star Equity stock or one of its competitors? MarketBeat compares Star Equity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Star Equity include CVRx (CVRX), Avita Medical (RCEL), Nano-X Imaging (NNOX), Solana (HSDT), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

How does Star Equity compare to CVRx?

CVRx (NASDAQ:CVRX) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

CVRx presently has a consensus price target of $11.50, suggesting a potential upside of 89.77%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 161.83%. Given Star Equity's higher possible upside, analysts plainly believe Star Equity is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

CVRx has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Star Equity has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market.

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Star Equity	-4.18%	-4.04%	-2.40%

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.84	-$53.31M	-$2.02	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

In the previous week, Star Equity had 14 more articles in the media than CVRx. MarketBeat recorded 19 mentions for Star Equity and 5 mentions for CVRx. CVRx's average media sentiment score of 0.43 beat Star Equity's score of -0.12 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

75.3% of CVRx shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 13.9% of CVRx shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

CVRx and Star Equity tied by winning 8 of the 16 factors compared between the two stocks.

How does Star Equity compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 33.5% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Avita Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

Star Equity has a net margin of -4.18% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Star Equity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Star Equity	-4.18%	-4.04%	-2.40%

Star Equity has higher revenue and earnings than Avita Medical. Star Equity is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.86	-$48.59M	-$1.57	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

In the previous week, Star Equity had 7 more articles in the media than Avita Medical. MarketBeat recorded 19 mentions for Star Equity and 12 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.38 beat Star Equity's score of -0.12 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical currently has a consensus target price of $7.25, suggesting a potential upside of 67.82%. Star Equity has a consensus target price of $28.00, suggesting a potential upside of 161.83%. Given Star Equity's stronger consensus rating and higher probable upside, analysts clearly believe Star Equity is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

Star Equity beats Avita Medical on 9 of the 17 factors compared between the two stocks.

How does Star Equity compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Star Equity has a net margin of -4.18% compared to Nano-X Imaging's net margin of -790.87%. Star Equity's return on equity of -4.04% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
Star Equity	-4.18%	-4.04%	-2.40%

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 3.8% of Star Equity shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 33.5% of Star Equity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Star Equity had 15 more articles in the media than Nano-X Imaging. MarketBeat recorded 19 mentions for Star Equity and 4 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.21 beat Star Equity's score of -0.12 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nano-X Imaging presently has a consensus price target of $5.00, suggesting a potential upside of 176.24%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 161.83%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Star Equity has higher revenue and earnings than Nano-X Imaging. Star Equity is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.67	-$75.02M	-$1.59	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

Nano-X Imaging has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

Summary

Nano-X Imaging beats Star Equity on 9 of the 16 factors compared between the two stocks.

How does Star Equity compare to Solana?

Star Equity (NASDAQ:STRR) and Solana (NASDAQ:HSDT) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

3.8% of Star Equity shares are owned by institutional investors. Comparatively, 18.6% of Solana shares are owned by institutional investors. 33.5% of Star Equity shares are owned by company insiders. Comparatively, 14.4% of Solana shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Star Equity has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Solana has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

Star Equity has higher revenue and earnings than Solana. Star Equity is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A
Solana	$6.02M	22.41	-$40.89M	-$109.67	N/A

Star Equity currently has a consensus target price of $28.00, suggesting a potential upside of 161.83%. Solana has a consensus target price of $3.50, suggesting a potential upside of 51.52%. Given Star Equity's higher possible upside, equities research analysts clearly believe Star Equity is more favorable than Solana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Star Equity has a net margin of -4.18% compared to Solana's net margin of -1,427.15%. Star Equity's return on equity of -4.04% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Solana	-1,427.15%	-67.57%	-24.09%

In the previous week, Star Equity had 13 more articles in the media than Solana. MarketBeat recorded 19 mentions for Star Equity and 6 mentions for Solana. Star Equity's average media sentiment score of -0.12 beat Solana's score of -0.34 indicating that Star Equity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solana	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Star Equity beats Solana on 10 of the 15 factors compared between the two stocks.

How does Star Equity compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

Star Equity has higher revenue and earnings than Nyxoah. Star Equity is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	9.78	-$101.92M	-$2.48	N/A
Star Equity	$172.16M	0.23	-$5.92M	-$2.63	N/A

Nyxoah currently has a consensus target price of $7.67, indicating a potential upside of 168.07%. Star Equity has a consensus target price of $28.00, indicating a potential upside of 161.83%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

3.8% of Star Equity shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 33.5% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Star Equity had 16 more articles in the media than Nyxoah. MarketBeat recorded 19 mentions for Star Equity and 3 mentions for Nyxoah. Nyxoah's average media sentiment score of 0.42 beat Star Equity's score of -0.12 indicating that Nyxoah is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nyxoah	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Star Equity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Star Equity has a net margin of -4.18% compared to Nyxoah's net margin of -543.21%. Star Equity's return on equity of -4.04% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
Star Equity	-4.18%	-4.04%	-2.40%

Nyxoah has a beta of 1.56, meaning that its stock price is 56% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

Summary

Star Equity beats Nyxoah on 10 of the 17 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STRR vs. The Competition

Export

Metric	Star Equity	DIVERSIFIED OPS Industry	Multi-Sector Sector	NASDAQ Exchange
Market Cap	$37.37M	$20.17B	$18.42B	$12.12B
Dividend Yield	N/A	3.80%	3.60%	5.36%
P/E Ratio	-4.07	29.31	24.53	25.21
Price / Sales	0.23	13.51	11.37	73.06
Price / Cash	15.96	50.52	48.22	55.00
Price / Book	0.65	4.65	4.10	6.94
Net Income	-$5.92M	$952.31M	$939.12M	$335.25M
7 Day Performance	12.45%	-1.80%	-1.70%	-0.70%
1 Month Performance	13.28%	1.63%	0.04%	-0.90%
1 Year Performance	392.81%	23.55%	19.46%	29.67%

Star Equity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STRR Star Equity	3.7941 of 5 stars	$10.69 +5.8%	$28.00 +161.8%	+319.5%	$37.37M	$172.16M	N/A	1,200	Analyst Revision
CVRX CVRx	3.2958 of 5 stars	$5.22 -0.9%	$11.50 +120.3%	-12.3%	$137.97M	$56.65M	N/A	160
RCEL Avita Medical	3.0415 of 5 stars	$4.26 -2.7%	$6.63 +55.5%	-37.7%	$131.12M	$71.61M	N/A	130	Earnings Report
NNOX Nano-X Imaging	3.1713 of 5 stars	$1.79 +4.7%	$5.00 +179.3%	-68.4%	$124.57M	$13.02M	N/A	190
HSDT Solana	3.5067 of 5 stars	$2.21 +5.2%	$3.50 +58.4%	-99.1%	$121.31M	$6.02M	N/A	30	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STRR) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Star Equity (STRR) Competitors